Evidence map›Paper›PMID 26301427›Full record

ArticleJournal of the American Chemical Society2015

Ribosome-Mediated Incorporation of Dipeptides and Dipeptide Analogues into Proteins in Vitro.

Rumit Maini, Larisa M Dedkova, Rakesh Paul, Manikandadas M Madathil, Sandipan Roy Chowdhury, Shengxi Chen, Sidney M Hecht

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Ribosome engineering enhances genetic code expansion inSynthetic and systems biotechnology · 2027
    Article
  3. Article
  4. Article
  5. Biological Regulation StudiedAccounts of chemical research · 2025
    Article
  6. Article
  7. Review
  8. RNA language models predict mutations that improve RNA function.bioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Review
  11. Engineered mRNA-ribosome fusions for facile biosynthesis of selenoproteins.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cell-free Biosynthesis of Peptidomimetics.Biotechnology and bioprocess engineering : BBE · 2023
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rumit MainiCenter for BioEnergetics, Biodesign Institute, and Department of Chemistry & Biochemistry, Arizona State University , Tempe, Arizona 85287, United States.
Larisa M DedkovaCenter for BioEnergetics, Biodesign Institute, and Department of Chemistry & Biochemistry, Arizona State University , Tempe, Arizona 85287, United States.
Rakesh PaulCenter for BioEnergetics, Biodesign Institute, and Department of Chemistry & Biochemistry, Arizona State University , Tempe, Arizona 85287, United States.
Manikandadas M MadathilCenter for BioEnergetics, Biodesign Institute, and Department of Chemistry & Biochemistry, Arizona State University , Tempe, Arizona 85287, United States.
Sandipan Roy ChowdhuryCenter for BioEnergetics, Biodesign Institute, and Department of Chemistry & Biochemistry, Arizona State University , Tempe, Arizona 85287, United States.
Shengxi ChenCenter for BioEnergetics, Biodesign Institute, and Department of Chemistry & Biochemistry, Arizona State University , Tempe, Arizona 85287, United States.
Sidney M HechtCenter for BioEnergetics, Biodesign Institute, and Department of Chemistry & Biochemistry, Arizona State University , Tempe, Arizona 85287, United States.
Arizona State University · USBioEnergetics (United States) · US

Funding

Selection of Modified Ribosomes Using Novel PuromycinsR01GM103861 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI HECHT, SIDNEY M. · 2013 to 2021
$1.6M
NIGMS NIH HHS GM103861NIGMS NIH HHS R01 GM103861
6 · The paper itself

Abstract

Plasmids containing 23S rRNA randomized at positions 2057-2063 and 2502-2507 were introduced into Escherichia coli, affording a library of clones which produced modified ribosomes in addition to the pre-existing wild-type ribosomes. These clones were screened with a derivative of puromycin, a natural product which acts as an analogue of the 3'-end of aminoacyl-tRNA and terminates protein synthesis by accepting the growing polypeptide chain, thereby killing bacterial cells. The puromycin derivative in this study contained the dipeptide p-methoxyphenylalanylglycine, implying the ability of the modified ribosomes in clones sensitive to this puromycin analogue to recognize dipeptides. Several clones inhibited by the puromycin derivative were used to make S-30 preparations, and some of these were shown to support the incorporation of dipeptides into proteins. The four incorporated species included two dipeptides (Gly-Phe (2) and Phe-Gly (3)), as well as a thiolated dipeptide analogue (4) and a fluorescent oxazole (5) having amine and carboxyl groups approximately the same distance apart as in a normal dipeptide. A protein containing both thiolated dipeptide 4 and a 7-methoxycoumarin fluorophore was found to undergo fluorescence quenching. Introduction of the oxazole fluorophore 5 into dihydrofolate reductase or green fluorescent protein resulted in quite strong enhancement of its fluorescence emission, and the basis for this enhancement was studied. The aggregate results demonstrate the feasibility of incorporating dipeptides as a single ribosomal event, and illustrate the lack of recognition of the central peptide bond in the dipeptide, potentially enabling the incorporation of a broad variety of structural analogues.

Indexed as

DipeptidesGreen Fluorescent ProteinsModels, MolecularProtein ConformationRibosomesTetrahydrofolate DehydrogenaseDipeptidesGreen Fluorescent ProteinsTetrahydrofolate Dehydrogenase

Identifiers

PMID26301427
PMCPMC5724524
OpenAlexW1149835906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.